Strikingly, when we used the anti-Ly6C antibody (clone Monts 1) to block Ly6C, the resistance to anti-PD-1/CTLA-4 was completely suppressed in the aggressive KP 344SQ tumor model (Figures 2E, S2A). This evidence concerns the gene CTLA4 and neoplasm.